Maxillary Segment Tipping During Transpalatal Distraction

NCT ID: NCT04041388

Last Updated: 2019-08-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-09-01

Study Completion Date

2020-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigator proposes a multi-centre study to investigate tipping of teeth, bringing into consideration the height of the osteotomy line and the height and placement of the transpalatal distractor as possible factors. If tipping occurs depending on these factors, the investigator could identify the situations that cannot be straightened by the orthodontist and provide another course of action for these specific patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Surgically Assisted Rapid Maxillary Expansion (SARME) is widely accepted for the treatment of maxillary hypoplasia. The differences between SARME with a tooth-borne or a bone-borne distractor have already been extensively investigated, bringing to light that a bone-borne distractor has less negative side effects. One of the major concerns with the tooth-borne distractor is the tipping of the anchor teeth, which is bypassed by the bone-borne distractor which applies its force directly on the bone. One study investigated the tipping of teeth with a bone-borne distractor in 10 patients, showing that there was a minor change in the tooth axis. The investigator proposes a multi-center study to investigate this tipping further, bringing into consideration the height of the osteotomy line and the height and placement of the transpalatal distractor as possible factors. If tipping occurs depending on these factors, the investigator could identify the situations that cannot be straightened by the orthodontist and provide another course of action for these specific patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Maxillary Hypoplasia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Tooth tipping

Group Type OTHER

Conebeam CT

Intervention Type OTHER

medical imaging technique consisting of X-ray computed tomography where the X-rays are divergent, forming a cone

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Conebeam CT

medical imaging technique consisting of X-ray computed tomography where the X-rays are divergent, forming a cone

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Undergoing a surgically assisted rapid maxillary expansion with a bone borne transpalatal distractor.
* Cone beam CT pre op and 3 weeks post op is available

Exclusion Criteria

* Complication of the process by e.g. surgical site infection
* Asymmetrical expansion of more than 3.0 mm measured at the central incisivae occurred
Minimum Eligible Age

14 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universitair Ziekenhuis Brussel

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Veerle Van Mossevelde

Study Coordinator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Wendy Van Bogaert, MD

Role: PRINCIPAL_INVESTIGATOR

Universitair Ziekenhuis Brussel

Maurice Mommaerts, Prof MULT

Role: STUDY_DIRECTOR

Universitair Ziekenhuis Brussel

Nathalie Loomans, MD

Role: STUDY_CHAIR

GasthuisZusters Antwerpen (GZA)

Yannick Spaey, MD

Role: STUDY_CHAIR

Mariaziekenhuis Noord-Limburg

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Universitair Ziekenhuis Brussel

Jette, Vlaams Brabant, Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Veerle Van Mossevelde, SC

Role: CONTACT

+3224763134

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TPD Studie v 1.0

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.